Real-world evidence for repurposing hydralazine as a potential epigenetic modulator for psoriasis: a 16-year retrospective nationwide cohort study
Abstract Background Dysregulated DNA methylation and hypertension (HTN) are closely associated with the development of psoriasis. However, the impact of the vasodilator hydralazine (HLZ), which also inhibits DNA methyltransferase, on psoriasis risk remains unclear. This study investigated the associ...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-11-01
|
| Serija: | Journal of Translational Medicine |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s12967-025-07322-4 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|